Retrospective study of Programmed cell death protein 1 (PD-1)-inhibition in hepatocellular carcinoma
Latest Information Update: 01 Sep 2021
At a glance
- Drugs Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 01 Sep 2021 New trial record